News archive

DNTOX GmbH, based in Düsseldorf, Germany, is a bio-analytical testing laboratory that screens chemicals for its potential to disrupt human brain development and cause developmental neurotoxicity (DNT) without using animals. With its service, the research team has convinced investors and can now dispose of 1.4 million euros in start-up funding.

An article from Nature Medicine provides a good insight into the current debate about the recognition of results from animal-free methods in drug development.

A few days ago, the Environmental Protection Act, Bill S-5, was revised in Canada. It includes amendments that require the Canadian government to replace or reduce animal testing for toxicity testing of chemicals where possible and to publish a plan within the next two years to encourage the development and timely incorporation of alternative strategies for toxicity testing.

The Eva Luise and Horst Köhler Foundation, in cooperation with the association ACHSE e. V., has offered a research prize for rare diseases since 2008.

Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), headed by Prof. Dr. Claus-Michael Lehr, have developed a novel method to specifically place biofilms on lung cells in the laboratory. The model system produced by means of "bioprinting" should help to better understand infection processes and assist in the research of new active substances.

The annual Eppendorf & Science Prize for Neurobiology is an international award which honors early-career scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology.

On May 31 and June 1, the European Chemicals Agency (ECHA) hosted a two-day workshop in Helsinki to discuss with various stakeholders how to accelerate the transition to an animal-free chemical evaluation system. The main goal of the workshop was to better understand each other, as all stakeholders took different perspectives. Meanwhile, researchers are considering how an exit strategy could succeed.

According to a report in the medical journal "Ärzteblatt", the German Society for Endocrinology (DGE) has spoken out in favor of further reducing animal experiments. That could also succeed, because animal-free methods become ever better, so DGE vice-president Jan Tuckermann.

The mouse in autism research is this year's laboratory animal of the year. In this english issue, the German Association for Animal Rights discusses the reasons why the rodent is not a suitable research "model" and presents animal-free methods.

In order to find a way to treat aggressive and persistent tumors of the nervous system in children, called neuroblastomas, researchers from Berlin, Cologne, Würzburg and Tübingen are taking a new, interdisciplinary approach.